Literature DB >> 8921922

Quantitative and qualitative assessments of pain in children with juvenile chronic arthritis based on the Norwegian version of the Pediatric Pain Questionnaire.

B Benestad1, O Vinje, M B Veierød, I H Vandvik.   

Abstract

Quantitative and qualitative aspects of pain were studied using a standardized questionnaire (the Varni/Thompson Pediatric Pain Questionnaire--PPQ). Fifty-seven of 64 consecutive in- and out-patients (6-18 yrs) with juvenile chronic arthritis (pauciart. n = 27, polyart. n = 30) and 52 parents participated. The patients were examined by the same rheumatologist and randomly interviewed by either a disabled or a non-disabled person. Present pain, worst pain intensity and disease severity were scored (on visual analogue scales [10 cm. VAS]) by patients, parents and rheumatologist. Eighty-two percent of the children reported pain lasting from 30 min up to 24 h daily (mean 4.3 h). No significant differences were found between median pain scores of children, parents and the physician, but the correlations found between children's and parent's assessment of pain and assessment of disease severity were low, indicating that the two sets of raters did not agree to an acceptable level. Two-thirds of the adolescents reported that they would become more physically active if pain disappeared. Should the pain suddenly vanish, a positive change in family relationships was anticipated by one out of four patients. Forty-two percent of the patients thought it valuable to be interviewed by a disabled physician. The Norwegian Varni/Thompson PPQ is easy to administer to children down to six years and makes it possible to compare results internationally. Lack of agreement on the assessment of pain by a child and his/her parent indicates the need to interview both parties.

Entities:  

Mesh:

Year:  1996        PMID: 8921922     DOI: 10.3109/03009749609104061

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  8 in total

Review 1.  Qualitative Methods to Advance Care, Diagnosis, and Therapy in Rheumatic Diseases.

Authors:  Lesley Ann Saketkoo; John D Pauling
Journal:  Rheum Dis Clin North Am       Date:  2018-02-21       Impact factor: 2.670

2.  Toxicity of antirheumatic and anti-inflammatory drugs in children.

Authors:  B Flatø; O Vinje; O Førre
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Nitrous oxide analgesia during intra-articular injection for juvenile idiopathic arthritis.

Authors:  A G Cleary; A V Ramanan; E Baildam; A Birch; J A Sills; J E Davidson
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

4.  The PedsQL Present Functioning Visual Analogue Scales: preliminary reliability and validity.

Authors:  Sandra A Sherman; Sarajane Eisen; Tasha M Burwinkle; James W Varni
Journal:  Health Qual Life Outcomes       Date:  2006-10-04       Impact factor: 3.186

5.  "Reluctant to Assess Pain": A Qualitative Study of Health Care Professionals' Beliefs About the Role of Pain in Juvenile Idiopathic Arthritis.

Authors:  Rebecca Rachael Lee; Amir Rashid; Wendy Thomson; Lis Cordingley
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-01       Impact factor: 4.794

6.  Pain experience in children with juvenile idiopathic arthritis treated with anti-TNF agents compared to non-biologic standard treatment.

Authors:  Johanne Jeppesen Lomholt; Mikael Thastum; Troels Herlin
Journal:  Pediatr Rheumatol Online J       Date:  2013-05-06       Impact factor: 3.054

7.  Impact of a telenursing service on satisfaction and health outcomes of children with inflammatory rheumatic diseases and their families: a crossover randomized trial study protocol.

Authors:  Anne-Sylvie Ramelet; Béatrice Fonjallaz; Joachim Rapin; Christophe Gueniat; Michaël Hofer
Journal:  BMC Pediatr       Date:  2014-06-18       Impact factor: 2.125

8.  Pain in Tourette Syndrome-Children's and Parents' Perspectives.

Authors:  Agnieszka Małek
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.